26Apr

Free Workshop – “FIT to Practice?” Alpha Laboratories at ACB FOCUS 2018

Faecal Immunochemical Testing (FIT) is now an established diagnostic test that identifies the presence of minute quantities of haemoglobin (blood) in the stool, known as faecal occult blood (FOB), which can be an early sign of colorectal cancer. FIT uses antibodies specific to human haemoglobin so is more sensitive and has a greater specificity than the previous qualitative guaiac based methods. 

NICE DG30 now recommends the use of FIT to guide referral for colorectal cancer in primary care. At ACB Focus Mr Nigel D’Souza will present preliminary data from the NICE FIT study launched through Croydon University Hospital and RM Partners Accountable Cancer Network. As one of the largest studies on FIT it aims to recruit 5,500 patients to evaluate the diagnostic accuracy of FIT particularly in diverse populations.

Come and find out more about the NICE FIT study at Alpha Laboratories’ workshop on Thursday 7th June (9:50-10:30), or come and talk to our team on stand #6. The workshop is chaired by Professor Callum Fraser and Sally Benton, director of the Bowel Cancer Screening Hub in Guildford will also be present.

Please visit www.faecal-immunochemical-test.co.uk for further information or contact Alpha Laboratories on
0800 38 77 32 or email marketing@alphalabs.co.uk

Related

Sensitive, Reliable and Rapid Detection of Cryptococcal Infection

The IMMY CrAg® LFA (Cryptococcal Antigen Lateral Flow Assay) is the first and only immunochromatogra...

Read More >

OGT launches breakthrough CytoSure NGS panel for constitutional cytogenetics

Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one a...

Read More >

Veravas and MIP Diagnostics Announce International Agreement for Improved Diagnostics

CHARLESTON, S.C. and OAKDALE, Minn., March, 13 2020, - Veravas, Inc., an emerging diagnostic company...

Read More >

Game Changer for Bladder Cancer Diagnosis

ADXBLADDER, an exciting new non-invasive test for bladder cancer from Arquer Diagnostics Ltd. and di...

Read More >

BBI Solutions adds more antibodies to product range

BBI Solutions has continued to invest in its portfolio of antibodies and today announced the launch ...

Read More >

Press Release - Innovation lab celebrates one-year anniversary in future proofing diagnostics

A North East-based lab is celebrating one year since it was set up to accelerate the development of ...

Read More >